Technical analysis of Pharvaris N.V. (PHVS): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.
Price Performance
| 1 month | +7.50% |
| 3 months | -1.00% |
| Year-to-date | +20.83% |
| 1 year | +50.90% |
| 3 years | +81.44% |
| 5 years | +118.44% |
52-Week Range
| 52-week High | $43.25 |
| 52-week Low | $21.02 |
| Avg Volume (90d) | 719K |
Technical Indicators
| SMA 50 | $33.66 |
| SMA 200 | $31.00 |
| Beta | -2.58 |
| 30-day Volatility (annualised) | 42.2% |
| Price vs SMA 50 | -0.4% |
| Price vs SMA 200 | +8.2% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $27.75 | |
| 2026-01 | $27.05 | -2.5% |
| 2026-02 | $28.39 | +5.0% |
| 2026-03 | $28.25 | -0.5% |
| 2026-04 | $31.01 | +9.8% |
| 2026-05 | $30.16 | -2.7% |
| 2026-06 | $34.58 | +14.7% |
| 2026-07 | $32.62 | -5.7% |
| 2026-08 | $34.61 | +6.1% |
| 2026-09 | $31.72 | -8.4% |
| 2026-10 | $33.53 | +5.7% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-11 | $-0.82 | $2M |
| 2026-08-12 | $-0.75 | |
| 2026-05-12 | $-0.82 | |
| 2026-04-02 | $-0.71 | |
| 2025-11-12 | $-0.78 | |
| 2025-08-12 | $-0.87 | |
| 2025-05-13 | $-0.80 | |
Price
| Price | $33.53 (closing price, October 30, 2026) |
| Market Cap | $2.3B |
| Exchange | NASDAQ |
| Country | CH |
Valuation Ratios
| Price / Book | 6.78 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 11.94 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 24.30 |